STOCK TITAN

Marimed Stock Price, News & Analysis

MRMD OTC

Welcome to our dedicated page for Marimed news (Ticker: MRMD), a resource for investors and traders seeking the latest updates and insights on Marimed stock.

MariMed Inc. (MRMD) generates frequent news as a multi-state cannabis operator and cannabis consumer packaged goods company focused on branded products, facility operations, and regulatory developments. Its releases cover both corporate performance and brand-level activity across cultivation, production, and retail channels.

On this page, readers can follow MariMed’s earnings announcements, where the company discusses revenue trends, gross margins, net income or loss, and non-GAAP measures such as Adjusted EBITDA. These updates often include commentary on wholesale and retail performance, as well as progress on what management calls its "Expand the Brand" strategy to grow top-selling cannabis brands.

MariMed’s news flow also highlights product and brand developments. Examples include new limited-edition Betty’s Eddies™ fruit chews, extensions to the Nature’s Heritage™ product line, and initiatives for Vibations™ and InHouse™. The company reports on licensing and managed services agreements that bring its brands into additional states, as well as strategic decisions such as exiting specific markets after operational reviews.

In addition, MariMed issues releases on community and veteran-focused initiatives tied to its Thrive dispensaries and brands, along with commentary on major policy changes affecting cannabis, such as the rescheduling of cannabis at the federal level. Investors and observers can use this news feed to monitor how MariMed communicates its strategy, brand expansion, financial performance, and responses to regulatory and market changes over time.

Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.83%
Tags
none
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.13%
Tags
conferences
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.06%
Tags
none
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.32%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.87%
Tags
none
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.93%
Tags
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.28%
Tags
none
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.22%
Tags
none
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.21%
Tags
Rhea-AI Summary

MariMed Inc. (CSE: MRMD) has opened its third adult-use dispensary in Massachusetts under the brand Panacea Wellness in Beverly, enhancing its presence in the Boston area. This marks the company’s tenth dispensary across four states. The grand opening will occur from April 27 to April 29, featuring entertainment and free merchandise. The company also operates a cultivation facility in New Bedford and plans to maximize its footprint in Massachusetts, which generated $1.8 billion in cannabis sales in 2022. MariMed offers a range of premium cannabis products, including Nature’s Heritage and Betty’s Eddies. The company's strategic expansion demonstrates its commitment to capturing market share in a rapidly growing industry.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.66%
Tags
none

FAQ

What is the current stock price of Marimed (MRMD)?

The current stock price of Marimed (MRMD) is $0.071 as of April 20, 2026.

What is the market cap of Marimed (MRMD)?

The market cap of Marimed (MRMD) is approximately 28.2M.